The goal of the IPNP is to conduct leading-edge basic and translational research in psychiatry and neuroscience. For this purpose, the IPNP brings together cutting-edge experimental techniques and advanced methodologies to reach a mechanistic understanding of biological processes in the healthy brain and in neurological and psychiatric-related diseases.
The teams address projects in and be assigned to the following scientific domains:
1/ Neuro-Development and Psychiatry : including the teams Angulo, Galli, Huberfeld, Koukouli, Krebs, Oppenheim, Pardi, Pierani, Ramoz/Gorwood, Rebholz.
2/ Memory, Behavior and Emotions : including the teams Böhm, Galli, Huberfeld, Koukouli, Krebs, Oppenheim, Pardi, Ramoz/Gorwood, Rebholz.
3/ Neuro-Vascular System : including the teams Huberfeld, Joutel, Lenkei, Oppenheim, Turc
4/ Brain Cell Biology: including the teams Angulo, Böhm, Galli, Huberfeld, Joutel, Lenkei, Pierani, Rebholz, Van Niel.
-and the following cross-cutting domains:
Brain Tumors with both clinical and basic research,
Multiscale Imaging from molecules to whole brain,
Translational Neuropsychiatry
To this end, teams use multidisciplinary approaches such as genetics, epigenetics, biochemistry, biophysics, cell biology, developmental biology, electrophysiology, neurovascular physiology, optogenetics, behavior, brain imaging, clinical neuroscience, innovative therapeutics and pharmacology.
To reach a high level in research and innovation activities, researchers benefit from active investment in common services and facilities, including Technology Platforms: modern rodent facility (Animal House,), a zebrafish aquarium, as well as platforms for Biochemistry and Biophysics (B&B), Bioinformatics (BIPB), Cell and Tissue Imaging and Cell Culture (NeurImag) and Behavioral Phenotyping (PhenoBrain). Furthermore, multidisciplinary research is reinforced by local collaborations with clinicians in psychiatry, neurovascular diseases, brain tumors and brain imaging.